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femoral access in our institution between August 2009 to October 2013 with a 6
months follow-up. Primary end point was the presence of VC deﬁned as a composite
of hematoma> 6 cm, recurrent bleeding, pseudoaneurysm, arteriovenous ﬁstula,
arterial thrombosis or retroperitoneal bleeding.
Results: 404 (48.8%) patients received Angio-Seal and 423 (51,2%) Exo-Seal. 39
(4,7%) patients had a VC with a similar incidence of events between the 2 VCDs: 18
(4,4%) in Angio-Seal and 21 (4,9%) in Exo-Seal (p¼0.7). Risk of VC was
signiﬁcantly associated with body mass index (p¼0.01), sheath size (p¼0.04), pres-
ence of chronic kidney disease (p¼0.005) and peripheral arterial disease (p¼0.03).
There was no fatal complications. Most of the pseudoaneurysms were resolved with
compression and/or thrombin, only 2 of them and 1 retroperitoneal bleeding required
vascular surgery.
Conclusions: Although radial approach is increasing in recent years, femoral
remains the most frequent in primary PCI. VC after femoral VCDs in patients un-
dergoing primary PCI, have a low but not negligible incidence despite being implanted
by interventional cardiologists experienced in femoral access. VC were signiﬁcantly
associated with individual (body mass index, chronic kidney disease, peripheral arterial
disease) and procedure-related (sheath size) characteristics. Safety and efﬁcacy of both
(Angio-Seal and Exo-Seal) VCDs is similar after primary PCI.TCT-848
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Background: Vascular closure device (VCD) based venous closure has been anec-
dotally reported but systematic evaluation of the reparative response of the vessel wall
to venous closure is lacking. The need to control groin complications, and minimize
risks associated with postponed sheath removal under conditions of persistent anti-
coagulation, has generated interest in the role of vascular closure devices for venous
access closure. We sought to characterize the vessel wall response to venous closure,
both acutely and in delayed fashion at 30 days using angiography, ultrasound and
histology.
Methods: Ten (10) venous 7F sheaths were deployed in the femoral veins of swine.
Bilateral venous access sites were subsequently closed utilizing manual compression
(control arm, n¼4) or a closure device utilizing an extravascular polyethylene glycol
sealant (MynxGrip Treatment arm, n¼6). Acute (post-closure), 3-day and 30-day
vascular ultrasound, as well as venography was used to assess outcomes. Gross pa-
thology and histology were obtained at the 30 day endpoint for all femoral venous
closure sites.Each animal was evaluated for venous thromboembolism to downstream
tissues vena cava, heart, and lungs.
Results: Hemostasis was successfully achieved in all cases without access site
complications. Venography and ultrasound conﬁrmed normal ilio-femoral anatomy
and ﬂow at all study time points. Gross pathology and histopathology revealed no
evidence of deep vein thrombosis, and no abnormalities were seen in the vena cava,
heart or lungs. Histology (at 30 days) showed complete healing of the vein wall access
site, with a small focus of chronic inﬂammation and ﬁbrosis in the perivascular
adventitial tissue of the access tract. There was no microscopic evidence of the sealant.
The tissue tract showed mild discrete inﬂammation (foamy macrophages, lympho-
cytes, plasma cells) with micro-granulomas centered on residual red cells in both
treatment and control groups.
Conclusions: This study provides novel insight into healing mechanisms following
femoral vein closure and the bioresorptive role of MynxGrip extravascular sealant in
achieving effective venous closure, while preserving long term vessel patency without
thromboembolism.TCT-849
Preclosure of vascular access site with the suture-mediated ProGlide system
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Background: The ProGlide closure system is becoming popular for the percutaneous
delivery of suture for closing the vascular access site of patients who have undergone
structural interventional procedures using 5F to 21F sheaths. This study is intended to
demonstrate the safety, effectiveness and feasibility of a suture-mediated ProGlide for
access site closure after transfemoral transcatheter aortic valve implantation (TAVI)
and transfemoral MitraClip.
Methods: ProGlide closure was used between 2010 and 2013 in 57 patients in our
centre. The ProGlide sutures were deployed in a preclose technique before the
insertion of the large caliber sheath. Achieving effective hemostasis and no further
access site-related vascular or hemorrhagic complications during the whole hospital
stay is considered success of the closure technique.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/VasculResults: Patients were 73+/-6.5 years old with a logistic EuroSCORE of 22.2+/-12.4.
There were total of 57 patients deemed high risk as surgical candidates undergone
percutaneous therapy for transfemoral TAVI with Edwards SAPIEN valves (n¼31)
and MitraClip procedure (n¼26). The overall success rate of the ProGlide closure was
98.3%(one patient had diminished pulses distal to closure site that needed surgical
intervention). The success rate remained at 100% among the patients on dual anti-
platelet therapy (DAPT) or on anticoagulants. None of the patients that were examined
with ultrasound demonstrated an AV ﬁstula, aneurysm, hematoma or local thrombosis
related to the ProGlide device.
Conclusions: This study demonstrated that the suture-mediated ProGlide system is a
safe, simple and highly effective method to close the large arterial access site after
transfemoral TAVI and large venous sites of 24Fr as needed in patients undergoing
MitraClip procedure despite on platelet inhibitors or anticoagulation. Additionally, use
of the ProGlide system can result in shorter procedure time, duration to achieve he-
mostasis and also shorter length of hospital stay.TCT-850
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Background: Increasingly the trans-radial route (TR) is preferred over the trans-
femoral route (TF) for PCI. However even in high volume default TR centres a small
cohort of patients are required to undergo TF PCI. We examined the demographics,
procedural and bleeding outcomes of patients undergoing PCI via the TF in a single
high volume UK centre.
Methods: The patient demographics procedure and outcomes of 5379 patients un-
dergoing PCI between 2009 and 2012 were examined. 559(10.4%) patients underwent
PCI via the TF route reviewed for Hb drop 3g/dl or more, overt bleeding, Transfusion
with in 7 days post PCI, Doppler US/ CT abdomen.
Results: 559(10.4%) patients underwent PCI via the TF route and these patients were
more often female, older, lower body weight, shocked and undergoing complex
procedures than patients in the TR cohort. In the TF group 79 patients (16.4%)
experienced bleeding with 1 each BARC Type 5a and 5b bleed each, 3 BARC Type
3b bleeds, 17 Type 3a bleeds and 57 Type 2 bleeds. Within the TF cohort patients with
bleeding when compared to TF patients without bleeding were less likely to have
stable angina (13.9% vs. 38.5%, p< 0.0001), more likely to be undergoing primary
PCI (30.4% vs. 9.4%, p< 0.0001), present with cardiogenic shock (24.1% vs. 3.5%,
p< 0.0001), have sheath sizes greater than 6F used and have a lower BMI (26.0
vs. 32.3 in females and 27.2 vs. 30.0 in males). Mortality at 30 days (15.2% vs. 1.9%,
p < 0.0001) and 1 year (25.3% vs. 5.2%, p< 0.0001) was signiﬁcantly higher in the
bleeding group. Major bleeding was an independent predictor of 30 day and 1year
mortality.
Conclusions: In a high volume default TR centre the incidence of BARC-
deﬁned bleeding was extremely high in TF PCI patients with excess mortality at
30 days and 1 year. Therefore TF PCI cases undertaken in a default TR centre
cases require meticulous peri-procedural and post-procedural care to minimise
complications.ar Access and Intervention - Femoral (includes closure devices) B247
Demographics and procedural characteristics of the bleeding vs. no
bleeding in the femoral cohort
VARIABLES
No bleeding
n¼480
Bleeding
n¼79 p value
Female % 35.4 39.2 NS
Female Age years 67.5 67.8 NS
Male Age years 62.8 65.3 NS
BMI 28.70.24 27.50.77 NS
Weight kg 81.4 75.2 NS
Stable Angina % 36.3 13.9 <0.0001
Acute coronary syndrome % 63.7 86.1 NS
Cardiogenic shock % 3.5 24.1 <0.0001
Previous PCI % 26.0 27.9 0.74
Previous CABG % 14.4 12.7 0.69
Chronic renal failure % 5.0 11.4 0.025
Gp2b3a used % 12.5 27.8 0.0004
Embolic protection device used
%
2.0 0 0.219
Intra-aortic balloon pump used
%
3.75 24.0 <0.0001
Diagnostic device used % 10.4 10.1 NS
Rotablation used % 3.9 8.9 0.042
Left Main Stem % 5.6 12.7 0.019
Non-LMS % 94.3 87.3 0.019
Graft(s) % 9.1 3.1 NS
CTO % 21.1 6.8 <0.0001
6Fr sheath % 84.0 60.8 <0.0001
7Fr sheath % 7.5 21.5 <0.0001
8Fr sheath % 6.7 13.9 0.03
No. of vessels attempted 535 93 0.0958
No. of lesions attempted 731 130
Procedural success % 87.2% 92.4%
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Background: Recent advances in catheter techniques have resulted in an increased
number of complex percutaneous cardiac interventions requiring large venous access
and full anticoagulation. Manual compression (MC) has been the standard approach
to hemostasis and has been associated with signiﬁcant discomfort, delayed ambu-
lation, more involved nursing care, overdue hospital discharge and groin compli-
cations. Extravascular closure devices (ECD) do not have any intraluminal
components and use water-soluble, bioabsorbable, polyethyleneglycol matrix. ECDs,
like Mynx [AccessClosure,CA] are therefore an excellent choice for venous access
closure.
Methods: Between 2009 and 2012, 1521 patients underwent various cardiac in-
terventions requiring femoral vein access and had immediate post-catheterization
venous access site closure. We selected high risk patients for groin complications
(8F and or ACT>200 sec at closure) who underwent venous access closure with
either Mynx device (Mynx group, n¼ 277) or MC (control group, n¼204). Propensity
score analysis was used to control for confounding/bias. Bleeding Academic Research
Consortium (BARC) deﬁnition used for bleeding. Access site complications evaluated
at discharge and 4 weeks.
Results: A total of 481 veins were included in analysis. Baseline and procedural
characteristics were similar between groups. At closure, average ACT was higher
for Mynx group, 243 sec vs. 146 sec (p< 0.001). Failure to achieve hemostasis,
converting to MC for Mynx group or requiring extended MC (>30 min) for
control group, was signiﬁcantly reduced for Mynx compared to control group
(1.5% vs. 11%, p< 0.001). Mean time to ambulation was signiﬁcantly shorter for
Mynx group (3 hours vs. 7 h, p< 0.001). One hematoma noted in the Mynx group
vs 9 for control group (p¼ns). No episodes of signiﬁcant bleeding were noted
(BARC Type 2, 3 or 5) for the Mynx group while there was 1 patient in MC
group who developed subcutaneous hematoma conﬁrmed on venous ultrasound and
required surgery.
Conclusions: In this propensity score analysis of high risk patients, Mynx device use
for venous access site closure was associated with rapid hemostasis and early
ambulation compared to manual compression.bstracts/Vascular Access and Intervention - Femoral (includes closure devices)
